Investor area [00]

Hellenic Dynamics Plc, the first medical cannabis cultivator to list on the London Stock Exchange’s Main Market

Overview [01]

Founded in 2018, Hellenic Dynamics is a licensed cultivator and supplier of finished pharmaceutical standard medical cannabis products operating from a dedicated 195,506 square meter facility set in the rolling hills of Northern Greece. Hellenic Dynamics is specifically involved in the cultivation, production and export of tetrahydrocannabinol (“THC”) dominant strains of dried medical cannabis flowers and flower extracts to the growing medical cannabis markets across Europe, worth €4.09bn in 2019 and expected to reach €43.3bn by 2027, growing at a CAGR of 29.6% during this period.

Medical cannabis, especially in higher THC doses, has been approved for use in the United Kingdom and Germany plus 24 other European countries for conditions including but not limited to chronic pain, Spinal cord treatment, Anxiety, HIV/AIDS Appitite loss, Multiple Sclerosis, Crohn’s disease, PTSD, Chemotherapy side effects, Glaucoma, Anorexia, Lennox-Gastaut syndrome, Alzheimer’s, Dravet syndrome, Tourette’s syndrome, Intractable spasticity and Cachexia.

Hellenic was awarded its licence from the Greek government in 2019 for a total of 40,000 square meters of active cultivation area within our facility, with no limitations on the THC content of the cultivars grown, the overall volume of production or total export quantities of flowers per annum. This is one of the largest licences of its kind issued in Europe due to the size and scale of the facility and the high regulatory standards under which Hellenic Dynamics operates.

Hellenic Dynamics has an experienced management team with significant medial cannabis cultivation and business development experience. This skillset is underpinned by a number of high profile partnerships and collaboration agreements that cover all aspects of the Company’s marketing, sales, security and existing legislative and legal frameworks both domestically and for target European sales territories.

This is one of the largest licences of its kind issued in Europe due to the size and scale of the facility and the high regulatory standards under which Hellenic Dynamics operates. The licence has no limitations on the THC content of the cultivars grown, the overall volume of production or export quantities of flowers per annum

Hellenic Dynamics has an experienced management team with significant medial cannabis cultivation and business development experience. This skillset is underpinned by a number of high profile partnerships and collaboration agreements that cover all aspects of the Company’s marketing, sales, security and existing legislative and legal frameworks, both domestically and for target European sales territories.

Share price [02]

Elia doluptis sande omnitia perum il int esed que seniaernatem volorem impeles equiasp elessita nihil iunt, officiis et que lamusam fugit rempores et es aut labore alitinc ianditatecto eaquunt eliscient, cone plab idit, quam, sequam

Hellenic Dynamics

0.9
12.48.00pm

0.1

ANNOUNCEMENTS [03]

BRIEF – Non conet que santia quiassint idem alitas pore ea quodita tibero comni net mossite la
comnist oratum quamet prat quo doloria quo quae lates dolore iligni cus eseditio vellupis prat

[11/06/2021]

BRIEF – Non conet que santia quiassint idem alitas pore ea quodita tibero comni net mossite la
comnist oratum quamet prat quo doloria quo quae lates dolore iligni cus eseditio vellupis prat.

[08/06/2121]

BRIEF – Non conet que santia quiassint idem alitas pore ea quodita tibero comni net mossite la comnist oratum quamet prat quo doloria quo quae lates dolore iligni cus eseditio vellupis prat.

[08/06/2121]

Key Documents [04]

[03]

ANNUAL REPORT 2022

Our annual reports for 2021-2022

General Information [05]

Hellenic Dynamics PLCIncorporated in England and Wales with registered No. 14025108
The company is subject to the UK City Code on Takeovers and Mergers.

Registered Office Address21 Arlington Street
London
SW1A 1RN

Professional Advisors

[01] Financial Advisor
Cairn Financial
Advisors
3rd Floor, 80
Cheapside
London
EC2V 6EE

[02] Broker
Peterhouse Capital
3rd Floor, 80
Cheapside
London
EC2V 6EE

[03] Reporting
accountants
PKF Littlejohn LLP
15 Westferry Circus
London
E14 4HD

[04] Public & investor
relations
J&H Communications
13 Soho Square
London
W1D 3QF

[05] Registrars
SLC Registrars
42-50 Hersham Road
Walton-On-Thames
Surry
KT12 1RZ

Corporate Governance [08]

The Directors are committed to maintaining high standards of corporate governance, and propose, so far as is practicable given the Company’s size and nature, to comply with the QCA Code.

The Board has established Board Committees for Audit & Risk, Remuneration, Sales and Nominations and is committed to developing further policies and procedures which reflect the principles of good governance.

The Company has adopted a share dealing code for the Directors and will take steps to ensure compliance by the Directors and any relevant employees with the terms of this code.

The Directors have established financial controls and reporting procedures which are considered appropriate given the size of and structure of the Company. These controls will continue to be reviewed as the Company develops and will be revised accordingly.

The Directors have established financial controls and reporting procedures which are considered appropriate given the size of and structure of the Company. These controls will continue to be reviewed as the Company develops and will be revised accordingly.